866-997-4948(US-Canada Toll Free)

Motion Sickness Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Published By :

Transparency Market Research

Published Date : May 2018

Category :

Healthcare IT

No. of Pages : 166 Pages

Global Motion Sickness Treatment Market: Overview

Motion sickness is a common condition characterized by a set of symptoms such as dizziness, nausea, and fatigue experienced by a person while traveling. It is caused by difference in impulses received by perceived sense of motion by visual senses and vestibular system’s sense of movement. Conflict among those senses result in motion sickness. Motion sickness is estimated to be experienced by around 50% travelers; it is most widely witnessed among children and elderly people. Various prescription and OTC drugs and products are used to treat motion sickness and provide relief from its symptoms. Anticholinergic, antihistamines, and sympathomimetic are the most commonly used medications, while traditional remedies such as herbal medicines, homeopathic medicines, and others are also available as OTC products for treatment of motion sickness.

The global motion sickness treatment market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on treatment type, route of administration, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market has been provided in the overview section. The report provides key insights of the global motion sickness treatment market comprising global pipeline analysis, key mergers and acquisitions, OTC vs. prescription drug market assessment, and Porter’s Five Forces Analysis. Additionally, the competition landscape section comprises competitive matrix, key player’s market footprint by treatment type and region, key competitive business strategies, and company profiles with business overview to understand the competitive landscape in the market. The report also provides market attractiveness analysis by region, thereby presenting a thorough analysis of the overall competitive scenario in the global motion sickness treatment market.

Global Motion Sickness Treatment Market: Key Segments

Based on treatment type, the global motion sickness treatment market has been segmented into anticholinergic, antihistamines, and others. The report also offers overview of the global motion sickness treatment market based on oral, transdermal, and other routes of administration. The treatment type segments have been analyzed based on commercially available motion sickness treatment drug and product types, route of administration, and adoption of each treatment type. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of distribution channel, the global motion sickness treatment market has been segmented into retail pharmacies, online pharmacies, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Motion Sickness Treatment Market: Regional Outlook

Geographically, the global motion sickness treatment market has been segmented into five major regions and the key countries/sub-regions in the respective region: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the motion sickness treatment market are GlaxoSmithKline plc, Perrigo Company plc, Prestige Brands, Inc., WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals, Inc., Myungmoon Pharm Co., Ltd., Baxter International, Inc. and Reliefband Technologies LLC.

The global motion sickness treatment market has been segmented as follows:

Global Motion Sickness Treatment Market, by Treatment Type

  • Anticholinergic
  • Antihistamines
  • Others (sympathomimetic, traditional medicines, wearable relief bands, etc.)

Global Motion Sickness Treatment Market, by Route of Administration

  • Oral
  • Transdermal
  • Others

Global Motion Sickness Treatment Market, by Distribution Channel

  • Retail Pharmacies
  • Online Pharmacies
  • Others (drug stores and hospital pharmacies)

Global Motion Sickness Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Motion Sickness Treatment Market

4. Market Overview
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.1. Restraints
4.3. Global Motion Sickness Treatment Market Analysis and Forecast, 2016–2026
4.3.1. Market Revenue Projections (US$ Mn)
4.4. Porter’s Five Force Analysis

5. Market Outlook
5.1.Pipeline Analysis
5.2.Key Mergers & Acquisitions
5.3.OTC & Prescription Market Analysis

6. Global Motion Sickness Treatment Market Analysis and Forecasts, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Treatment Type, 2016–2026
6.3.1. Anticholinergic
6.3.2. Antihistamines
6.3.3. Others
6.4. Market Attractiveness, by Treatment Type

7. Global Motion Sickness Treatment Market Analysis and Forecasts, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Route of Administration, 2016–2026
7.3.1. Oral
7.3.2. Transdermal
7.3.3. Others
7.4. Market Attractiveness, by Route of Administration

8. Global Motion Sickness Treatment Market Analysis and Forecasts, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Distribution Channel, 2016–2026
8.3.1. Retail Pharmacies
8.3.2. Online Pharmacies
8.3.3. Others
8.4. Market Attractiveness, by Distribution Channel

9. Global Motion Sickness Treatment Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region

10. North America Motion Sickness Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Treatment Type, 2016–2026
10.2.1. Anticholinergic
10.2.2. Antihistamines
10.2.3. Others
10.3. Market Value Forecast, by Route of Administration, 2016–2026
10.3.1. Oral
10.3.2. Transdermal
10.3.3. Others
10.4. Market Value Forecast, by Distribution Channel, 2016–2026
10.4.1. Retail Pharmacies
10.4.2. Online Pharmacies
10.4.3. Others
10.5. Market Value Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Treatment Type
10.6.2. By Route of Administration
10.6.3. By Distribution Channel
10.6.4. By Country

11. Europe Motion Sickness Treatment Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Treatment Type, 2016–2026
11.2.1. Anticholinergic
11.2.2. Antihistamines
11.2.3. Others
11.3.Market Value Forecast, by Route of Administration, 2016–2026
11.3.1. Oral
11.3.2. Transdermal
11.3.3. Others
11.4.Market Value Forecast, by Distribution Channel, 2016–2026
11.4.1. Retail Pharmacies
11.4.2. Online Pharmacies
11.4.3. Others
11.5.Market Value Forecast, by Country / Sub-region, 2016–2026
11.5.1. Germany
11.5.2. France
11.5.3. U.K.
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6.Market Attractiveness Analysis
11.6.1. By Treatment Type
11.6.2. By Route of Administration
11.6.3. By Distribution Channel
11.6.4. By Country / Sub-region

12. Asia Pacific Motion Sickness Treatment Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Treatment Type, 2016–2026
12.2.1. Anticholinergic
12.2.2. Antihistamines
12.2.3. Others
12.3.Market Value Forecast, by Route of Administration, 2016–2026
12.3.1. Oral
12.3.2. Transdermal
12.3.3. Others
12.4.Market Value Forecast, by Distribution Channel, 2016–2026
12.4.1. Retail Pharmacies
12.4.2. Online Pharmacies
12.4.3. Others
12.5.Market Value Forecast, by Country / Sub-region, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6.Market Attractiveness Analysis
12.6.1. By Treatment Type
12.6.2. By Route of Administration
12.6.3. By Distribution Channel
12.6.4. By Country / Sub-region

13. Latin America Motion Sickness Treatment Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Treatment Type, 2016–2026
13.2.1. Anticholinergic
13.2.2. Antihistamines
13.2.3. Others
13.3.Market Value Forecast, by Route of Administration, 2016–2026
13.3.1. Oral
13.3.2. Transdermal
13.3.3. Others
13.4.Market Value Forecast, by Distribution Channel, 2016–2026
13.4.1. Retail Pharmacies
13.4.2. Online Pharmacies
13.4.3. Others
13.5.Market Value Forecast, by Country, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6.Market Attractiveness Analysis
13.6.1. By Treatment Type
13.6.2. By Route of Administration
13.6.3. By Distribution Channel
13.6.4. By Country / Sub-region

14. Middle East & Africa Motion Sickness Treatment Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2.Market Value Forecast, by Treatment Type, 2016–2026
14.2.1. Anticholinergic
14.2.2. Antihistamines
14.2.3. Others
14.3.Market Value Forecast, by Route of Administration, 2016–2026
14.3.1. Oral
14.3.2. Transdermal
14.3.3. Others
14.4.Market Value Forecast, by Distribution Channel, 2016–2026
14.4.1. Retail Pharmacies
14.4.2. Online Pharmacies
14.4.3. Others
14.5.Market Value Forecast, by Country / Sub-region, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6.Market Attractiveness Analysis
14.6.1. By Treatment Type
14.6.2. By Route of Administration
14.6.3. By Distribution Channel
14.6.4. By Country / Sub-region

15. Competition Landscape
15.1.Market Player – Competition Matrix (By Tier and Size of companies)
15.2.Market Footprint Analysis
15.2.1. By Region
15.2.2. By Treatment Type
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. GlaxoSmithKline plc
   15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
   15.4.1.2.Product Portfolio
   15.4.1.3.Financial Overview
   15.4.1.4.SWOT Analysis
   15.4.1.5.Strategic Overview
15.4.2. Perrigo Company plc
   15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
   15.4.2.2.Product Portfolio
   15.4.2.3.Financial Overview
   15.4.2.4.SWOT Analysis
   15.4.2.5.Strategic Overview
15.4.3. Prestige Brands, Inc.
   15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
   15.4.3.2.Product Portfolio
   15.4.3.3.Financial Overview
   15.4.3.4.SWOT Analysis
   15.4.3.5.Strategic Overview
15.4.4. Wellspring Pharmaceutical Corporation
   15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
   15.4.4.2.Product Portfolio
   15.4.4.3.SWOT Analysis
   15.4.4.4.Strategic Overview
15.4.5. Caleb Pharmaceuticals, Inc.
   15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
   15.4.5.2.Product Portfolio
   15.4.5.3.SWOT Analysis
   15.4.5.4.Strategic Overview
15.4.6. Myungmoon Pharm CO., LTD.
   15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
   15.4.6.2.Product Portfolio
   15.4.6.3.Financial Overview
   15.4.6.4.SWOT Analysis
   15.4.6.5.Strategic Overview
15.4.7. Baxter International Inc.
   15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
   15.4.7.2.Product Portfolio
   15.4.7.3.Financial Overview
   15.4.7.4.SWOT Analysis
   15.4.7.5.Strategic Overview
15.4.8. Reliefband Technologies LLC
   15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
   15.4.8.2.Product Portfolio
   15.4.8.3.Financial Overview
   15.4.8.4.SWOT Analysis
   15.4.8.5.Strategic Overview

List of Table

Table 01: Pipeline Analysis (1/2)
Table 02: Pipeline Analysis (2/2)
Table 03: Key Mergers and Acquisitions Snapshot (1/2)
Table 04: Key Mergers and Acquisitions Snapshot (2/2)
Table 05: Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 06: Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 07: Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 08: Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 09: North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 10: North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 11: North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 12: North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 13: Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 14: Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 15: Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 16: Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 18: Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 19: Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 20: Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 22: Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 23: Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 24: Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country / Sub-region, 2016–2026
Table 25: Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 26: Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 27: Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 28: Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 29: Key Players Market Footprint Analysis, by Treatment Type
Table 30: Key Players Market Footprint Analysis, by Region

List of Chart

Figure 01: Global Motion Sickness Treatment Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 02: Global Motion Sickness Treatment
Figure 03: Top 3 Trends
Figure 04: Global Motion Sickness Treatment Market Value Share, by Region (2017)
Figure 05: Global Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 06: Global Market Value Share, by Treatment Type (2017)
Figure 07: Global Market Value Share, by Route of Administration (2017)
Figure 08: Global Market Value Share, by Distribution Channel (2017)
Figure 09: Global Market Value Share, by Region (2017)
Figure 10: OTC and Prescription Drugs Comparison Snapshot (2017)
Figure 11: Global Motion Sickness Treatment Market Value Share, by Treatment Type, 2017 and 2026
Figure 12: Global Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018–2026
Figure 13: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anticholinergic, 2016–2026
Figure 14: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antihistamines, 2016–2026
Figure 15: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 16: Global Motion Sickness Treatment Market Value Share, by Route of Administration, 2017 and 2026
Figure 17: Global Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018-2026
Figure 18: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral Drugs, 2016–2026
Figure 19: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Transdermal Drugs, 2016–2026
Figure 20: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 21: Global Motion Sickness Treatment Market Value Share, by Distribution Channel, 2017 and 2026
Figure 22: Global Motion Sickness Treatment Market Attractiveness, by Distribution Channel, 2018–2026
Figure 23: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2016–2026
Figure 24: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2016–2026
Figure 25: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 26: Global Motion Sickness Treatment Market Value Share, by Region, 2017 and 2026
Figure 27: Global Motion Sickness Treatment Market Attractiveness Analysis, by Region, 2018–2026
Figure 28: Market Snapshot, by Country
Figure 29: North America Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 30: North America Motion Sickness Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2026
Figure 31: North America Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018– 2026
Figure 32: North America Motion Sickness Treatment Market Value Share Analysis, by Route of Administration, 2017 and 2026
Figure 33: North America Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018–2026
Figure 34: North America Motion Sickness Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 35: North America Motion Sickness Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 36: North America Motion Sickness Treatment Market Value Share Analysis, by Country, 2017 and 2026
Figure 37: North America Motion Sickness Treatment Market Attractiveness Analysis, by Country, 2018–2026
Figure 38: Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 39: Europe Motion Sickness Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2026
Figure 40: Europe Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018–2026
Figure 41: Europe Motion Sickness Treatment Market Value Share Analysis, by Route of Administration, 2017 and 2026
Figure 42: Europe Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018–2026
Figure 43: Europe Motion Sickness Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 44: Europe Motion Sickness Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 45: Europe Motion Sickness Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 46: Europe Motion Sickness Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 47: Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 48: Asia Pacific Motion Sickness Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2026
Figure 49: Asia Pacific Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018–2026
Figure 50: Asia Pacific Motion Sickness Treatment Market Value Share Analysis, by Route of Administration, 2017 and 2026
Figure 51: Asia Pacific Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018–2026
Figure 52: Asia Pacific Motion Sickness Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 53: Asia Pacific Motion Sickness Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 54: Asia Pacific Motion Sickness Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 55: Asia Pacific Motion Sickness Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 56: Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 57: Latin America Motion Sickness Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2026
Figure 58: Latin America Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018–2026
Figure 59: Latin America Motion Sickness Treatment Market Value Share Analysis, by Route of Administration, 2017 and 2026
Figure 60: Latin America Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018–2026
Figure 61: Latin America Motion Sickness Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 62: Latin America Motion Sickness Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 63: Latin America Motion Sickness Treatment Market Value Share Analysis, by Country / Sub-region, 2017 and 2026
Figure 64: Latin America Motion Sickness Treatment Market Attractiveness Analysis, by Country / Sub-region, 2018–2026
Figure 65: Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 66: Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2026
Figure 67: Middle East & Africa Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018–2026
Figure 68: Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, by Route of Administration, 2017 and 2026
Figure 69: Middle East & Africa Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018–2026
Figure 70: Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 71: Middle East & Africa Motion Sickness Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 72: Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 73: Middle East & Africa Motion Sickness Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 74: Key Competitive Strategies Snapshot

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *